PLN 7.45
(-0.67%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.79 PLN | 4.82% |
2022 | -0.83 PLN | -66.0% |
2021 | -0.50 PLN | 15.25% |
2020 | -0.59 PLN | -15.69% |
2019 | -0.51 PLN | -2.0% |
2018 | -0.50 PLN | -233.33% |
2017 | -0.15 PLN | -56.09% |
2016 | -0.10 PLN | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.18 PLN | 5.26% |
2024 Q1 | -0.19 PLN | -11.76% |
2023 Q1 | -0.13 PLN | 59.38% |
2023 FY | - PLN | 4.82% |
2023 Q4 | -0.17 PLN | 15.0% |
2023 Q3 | -0.20 PLN | 20.0% |
2023 Q2 | -0.25 PLN | -92.31% |
2022 Q1 | -0.16 PLN | -134.6% |
2022 FY | - PLN | -66.0% |
2022 Q4 | -0.32 PLN | -88.24% |
2022 Q3 | -0.17 PLN | -6.25% |
2022 Q2 | -0.16 PLN | 0.0% |
2021 Q4 | -0.07 PLN | 54.53% |
2021 Q2 | -0.17 PLN | -126.67% |
2021 Q1 | -0.08 PLN | 78.57% |
2021 Q3 | -0.15 PLN | 11.76% |
2021 FY | - PLN | 15.25% |
2020 Q4 | -0.35 PLN | -285.46% |
2020 Q1 | -0.11 PLN | 57.69% |
2020 Q2 | -0.04 PLN | 63.64% |
2020 Q3 | -0.09 PLN | -127.0% |
2020 FY | - PLN | -15.69% |
2019 Q2 | -0.10 PLN | -39.77% |
2019 FY | - PLN | -2.0% |
2019 Q4 | -0.26 PLN | -116.67% |
2019 Q3 | -0.12 PLN | -22.82% |
2019 Q1 | -0.07 PLN | 65.05% |
2018 Q1 | -0.08 PLN | -64.14% |
2018 Q4 | -0.20 PLN | -125.99% |
2018 Q2 | -0.13 PLN | -67.1% |
2018 FY | - PLN | -233.33% |
2018 Q3 | -0.09 PLN | 31.92% |
2017 Q2 | -0.05 PLN | 0.0% |
2017 FY | - PLN | -56.09% |
2017 Q3 | -0.04 PLN | 8.41% |
2017 Q4 | -0.05 PLN | -11.53% |
2016 FY | - PLN | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Adiuvo Investments S.A. | -0.82 PLN | 3.659% |
Genomtec S.A. | -0.74 PLN | -6.757% |
Medicalgorithmics S.A. | -0.11 PLN | -618.182% |
Synektik Spólka Akcyjna | - PLN | Infinity% |